Puma Bio Bulls Win Monday's FDA Neratinib Review, Ahead of Wednesday's Advisory Panel Vote - TheStreet
News Release Puma Biotechnology Reports Third Quarter 2012
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Puma Biotechnology sinks after Europe unlikely to OK breast cancer drug - Nigeria News
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
Puma Biotechnology Announces Publication of Phase II Clinical Trial of Alisertib in JAMA Oncology | Business Wire
Puma Biotechnology
Puma Biotechnology (PBYI) Stock Climbs On Orphan Drug Designation | Alpha Stock News
Puma shares nearly triple on drug news, but options smell 'fishy'
The Prognosis For Puma Biotechnology (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology falls more than 20%
Conspiracy Theory: Did Puma Biotech Exec Resign Because of Bad News Ahead? | BioSpace
Goldman Sachs Group Cuts Stake in Puma Biotechnology (PBYI)
Here's Why Puma Biotechnology Fell 17.2% in April | The Motley Fool
Puma Biotechnology, Inc.
PumaBiotech (@pumabiotech) / Twitter
Stocks to Watch: Dropbox, Nike, Tronc, Qualcomm, Puma Biotechnology, Invitation Homes, Universal Display - WSJ
Puma Biotechnology - Updates, News, Events, Signals & Triggers
Puma Biotechnology Releases Updated Corporate Presentation
Puma Biotechnology Grants Inducement Stock Awards to New Non-Executive Employees.
Puma Biotechnology settles with Novartis' Sandoz unit over Nerlynx patent dispute (PBYI) | Seeking Alpha
Puma Biotechnology
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz
Former Puma Biotech executive gets U.S. prison term for insider trading
